CliffBio

Tersera Therapeutics

Patent cliffs & loss of exclusivity

Acquisition & Licensing

Company

Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/tersera-therapeutics
Full Address675 Cochrane Drive, East Tower Suite 600 Markham, Ontario L3R 0B8
LinkedIn URLhttp://www.linkedin.com/company/tersera
Pitchbook URLhttps://pitchbook.com/profiles/company/153231-49
Official Websitehttp://tersera.com

5 upcoming patent cliffs

DrugIngredientTypeCliff
  1. VARUBIROLAPITANT HYDROCHLORIDESmall mol.Oct 2029
  2. QMIIZ ODTMELOXICAMSmall mol.Aug 2030
  3. QMIIZ ODTMELOXICAMSmall mol.Aug 2030
  4. XERMELOTELOTRISTAT ETIPRATESmall mol.Feb 2031
  5. VARUBIROLAPITANT HYDROCHLORIDESmall mol.Jul 2032
  6. ZOLADEXGOSERELIN ACETATESmall mol.—
  7. ZOLADEXGOSERELIN ACETATESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Tersera Therapeutics — patent cliffs & loss of exclusivity | CliffBio